Bone metastasis of intrahepatic cholangiocarcinoma can be treated with targeted therapy and radiotherapy to improve the prognosis of the disease, and the treatment should be carried out under the guidance of professional doctors.
Bone metastasis of intrahepatic cholangiocarcinoma suggests that it enters the middle or late stage of cancer, and it is difficult to remove the lesion through surgical treatment. It is recommended to kill tumor cells and inhibit tumor growth and proliferation through radiotherapy and targeted therapy. It helps to improve the quality of life and prolong the life span as much as possible.
Commonly used chemotherapeutic drugs include carboplatin, paclitaxel, bleomycin, etc.; targeted drugs such as regrafenib, trametinib, etc. The drugs need to be used in strict compliance with the specifications of the doctor’s orders, and the emergence of adverse reactions, such as anemia, headache, etc., as soon as possible, and the use of drug allergy is prohibited.